Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis-Reference-Cited by-同舟云学术

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis

Published:2016-12-05 Issue:3 Volume:136 Page:233-238
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Tanasescu R.¹²,Midgley A.¹,Robins R. A.³,Constantinescu C. S.¹

Affiliation:

1. Division of Clinical Neuroscience; Clinical Neurology Research Group; Queen's Medical Centre; University of Nottingham; Nottingham University Hospitals NHS Trust; Nottingham UK

2. Department of Clinical Neurosciences; University of Medicine and Pharmacy Carol Davila; Department of Neurology; Colentina Hospital; Bucharest Romania

3. Division of Immunology; Clinical Neurology Research Group; Queen's Medical Centre; University of Nottingham; Nottingham University Hospitals NHS Trust; Nottingham UK

Funder

MS Society of the UK and Northern Ireland

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12715/fullpdf

Reference40 articles.

1. Current and future disease-modifying therapies in multiple sclerosis;Lim;Int J Clin Pract,2010

2. Therapeutic role of beta-interferons in multiple sclerosis;Javed;Pharmacol Ther,2006

3. Direct effects of type I interferons on cells of the immune system;Hervas-Stubbs;Clin Cancer Res,2011

4. Reciprocal effects of IFN-beta and IL-12 on STAT4 activation and cytokine induction in T cells;Fahey;J Leukoc Biol,2007

5. The role of endogenous IFN-beta in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis;Tao;J Immunol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic;QJM: An International Journal of Medicine;2021-01-25

2. PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis;Immunobiology;2021-01

3. Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients;Journal of Neuroinflammation;2018-03-07